Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Lin

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Blood Advances|September 10, 2021
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCTRoni Shouval, Joshua A Fein, Christina Cho, et al.
Cancer Cell|May 22, 2022
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignanciesRobert Stuver, Gunjan L Shah, Neha S Korde, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
The New England Journal of Medicine|February 27, 2020
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U Peled, Antonio L C Gomes, Sean M Devlin, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Blood Advances|September 10, 2021
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCTRoni Shouval, Joshua A Fein, Christina Cho, et al.
Cancer Cell|May 22, 2022
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignanciesRobert Stuver, Gunjan L Shah, Neha S Korde, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
The New England Journal of Medicine|February 27, 2020
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U Peled, Antonio L C Gomes, Sean M Devlin, et al.
Pageof 10